KAT6A and acute myeloid leukemia: These findings provide deeper insights into how chromatin architecture and histone modifications orchestrate oncogenic transcriptional programs, while also uncovering critical dependencies that may serve as therapeutic vulnerabilities in KAT6A-rearranged AML.